CareDx (CDNA) News Today $22.29 -1.09 (-4.66%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$22.55 +0.26 (+1.17%) As of 02/21/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. ShareholdersFebruary 21 at 10:09 AM | businesswire.comCareDx announces AlloSeq cfDNA study data published in Transplant InternationalFebruary 21 at 4:09 AM | markets.businessinsider.comCareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant PatientsFebruary 20 at 7:05 AM | businesswire.comAllspring Global Investments Holdings LLC Raises Stock Holdings in CareDx, Inc (NASDAQ:CDNA)Allspring Global Investments Holdings LLC boosted its stake in CareDx, Inc (NASDAQ:CDNA - Free Report) by 59.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 327,343 shares of the company's stock after buying aFebruary 20 at 3:14 AM | marketbeat.comCareDx (NASDAQ:CDNA) Rating Lowered to Hold at StockNews.comFebruary 20 at 2:05 AM | americanbankingnews.comStockNews.com Downgrades CareDx (NASDAQ:CDNA) to HoldStockNews.com downgraded shares of CareDx from a "buy" rating to a "hold" rating in a research report on Tuesday.February 19 at 11:12 PM | marketbeat.comCareDx (CDNA) to Release Earnings on WednesdayCareDx (NASDAQ:CDNA) will be releasing earnings after the market closes on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=664738)February 19 at 3:54 AM | marketbeat.comInvesting in CareDx (NASDAQ:CDNA) a year ago would have delivered you a 187% gainFebruary 12, 2025 | finance.yahoo.comSumitomo Mitsui Trust Group Inc. Reduces Stock Position in CareDx, Inc (NASDAQ:CDNA)Sumitomo Mitsui Trust Group Inc. trimmed its position in CareDx, Inc (NASDAQ:CDNA - Free Report) by 9.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,498,018 shares of the company's stock after selling 155,909 sharesFebruary 12, 2025 | marketbeat.comCareDx (NASDAQ:CDNA) Trading Down 5.5% - Here's WhyCareDx (NASDAQ:CDNA) Stock Price Down 5.5% - What's Next?February 11, 2025 | marketbeat.comCareDx to Report Fourth Quarter and Full Year 2024 Financial ResultsFebruary 11, 2025 | finance.yahoo.comCareDx (NASDAQ:CDNA) Sees Large Volume Increase - Time to Buy?CareDx (NASDAQ:CDNA) Sees Large Volume Increase - Here's WhyFebruary 10, 2025 | marketbeat.comCalamos Advisors LLC Sells 36,137 Shares of CareDx, Inc (NASDAQ:CDNA)Calamos Advisors LLC lessened its holdings in CareDx, Inc (NASDAQ:CDNA - Free Report) by 29.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 87,265 shares of the company's stock after selling 36,137 shares during the period. Calamos Advisors LLC oFebruary 5, 2025 | marketbeat.comCareDx, Inc (NASDAQ:CDNA) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of CareDx, Inc (NASDAQ:CDNA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the seven research firms that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and four have givenJanuary 31, 2025 | marketbeat.comCareDx (CDNA) Traded Down Due to Disappointing Quarterly ResultsJanuary 28, 2025 | finance.yahoo.comCareDx (NASDAQ:CDNA) Trading Down 5.4% - Should You Sell?CareDx (NASDAQ:CDNA) Stock Price Down 5.4% - Should You Sell?January 24, 2025 | marketbeat.comCareDx, Inc (NASDAQ:CDNA) Sees Significant Growth in Short InterestCareDx, Inc (NASDAQ:CDNA - Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 3,970,000 shares, a growth of 27.2% from the December 15th total of 3,120,000 shares. Based on an average trading volume of 811,600 shares, the days-to-cover ratio is currently 4.9 days. Currently, 7.9% of the company's shares are sold short.January 18, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for CareDx FY2024 Earnings?CareDx, Inc (NASDAQ:CDNA - Free Report) - Equities research analysts at HC Wainwright cut their FY2024 earnings per share (EPS) estimates for CareDx in a research report issued to clients and investors on Tuesday, January 14th. HC Wainwright analyst Y. Chen now forecasts that the company will earJanuary 17, 2025 | marketbeat.comCareDx upgraded to Equal Weight from Underweight at Wells FargoJanuary 16, 2025 | markets.businessinsider.comWells Fargo upgrades CareDx after a 30% pullback in stockJanuary 16, 2025 | msn.comWells Fargo Upgrades CareDx (CDNA)January 16, 2025 | msn.comCareDx (NASDAQ:CDNA) Upgraded to "Equal Weight" at Wells Fargo & CompanyWells Fargo & Company upgraded shares of CareDx from an "underweight" rating to an "equal weight" rating and cut their price target for the stock from $28.00 to $24.00 in a report on Wednesday.January 15, 2025 | marketbeat.comCareDx: Balancing Growth Prospects and Risks with a Hold RatingJanuary 14, 2025 | markets.businessinsider.comCareDx (NASDAQ:CDNA) Trading Down 6.1% - Should You Sell?CareDx (NASDAQ:CDNA) Trading Down 6.1% - Time to Sell?January 14, 2025 | marketbeat.comHC Wainwright Reiterates "Neutral" Rating for CareDx (NASDAQ:CDNA)HC Wainwright reissued a "neutral" rating and issued a $26.00 price target on shares of CareDx in a report on Tuesday.January 14, 2025 | marketbeat.comCraig-Hallum Remains a Buy on CareDx (CDNA)January 14, 2025 | markets.businessinsider.comCareDx (NASDAQ:CDNA) Sees Unusually-High Trading Volume - Should You Buy?CareDx (NASDAQ:CDNA) Sees Unusually-High Trading Volume - Here's WhyJanuary 13, 2025 | marketbeat.comCareDx sees Q4 revenue $85M-$86M, consensus $82.16MJanuary 13, 2025 | msn.comCareDx Expects Q4 30% Increase In Q4 Preliminary Revenue, Shares Up In PremarketJanuary 13, 2025 | markets.businessinsider.comCareDx guides Q4 revenue above estimatesJanuary 13, 2025 | msn.comCareDx Announces Preliminary Fourth Quarter and Full Year 2024 ResultsJanuary 13, 2025 | finance.yahoo.comCareDx Updates Director Compensation and Vesting PoliciesJanuary 8, 2025 | tipranks.comCareDx (NASDAQ:CDNA) Shares Up 4% - Here's What HappenedCareDx (NASDAQ:CDNA) Trading 4% Higher - Here's What HappenedJanuary 8, 2025 | marketbeat.comImplied Volatility Surging for CareDx (CDNA) Stock OptionsJanuary 6, 2025 | msn.comCareDx, Inc (NASDAQ:CDNA) Receives Consensus Rating of "Hold" from BrokeragesCareDx, Inc (NASDAQ:CDNA - Get Free Report) has received an average rating of "Hold" from the seven brokerages that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have given a buy recommJanuary 6, 2025 | marketbeat.comCareDx, Inc (NASDAQ:CDNA) Short Interest Down 6.6% in DecemberCareDx, Inc (NASDAQ:CDNA - Get Free Report) was the target of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 3,120,000 shares, a drop of 6.6% from the November 30th total of 3,340,000 shares. Based on an average daily volume of 842,500 shares, the short-interest ratio is currently 3.7 days. Approximately 6.2% of the company's stock are short sold.December 31, 2024 | marketbeat.comCareDx: Too Risky For MeDecember 30, 2024 | seekingalpha.comGeode Capital Management LLC Has $38.34 Million Stock Position in CareDx, Inc (NASDAQ:CDNA)Geode Capital Management LLC increased its stake in shares of CareDx, Inc (NASDAQ:CDNA - Free Report) by 2.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,227,724 shares of the company's stock afterDecember 25, 2024 | marketbeat.comCareDx: Top Of My Shopping List For 2025December 25, 2024 | seekingalpha.comBarclays PLC Acquires 54,482 Shares of CareDx, Inc (NASDAQ:CDNA)Barclays PLC lifted its holdings in shares of CareDx, Inc (NASDAQ:CDNA - Free Report) by 123.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 98,505 shares of the company's stock after purchasing an additional 54,482 shares during the periodDecember 24, 2024 | marketbeat.comPublic Employees Retirement System of Ohio Sells 38,966 Shares of CareDx, Inc (NASDAQ:CDNA)Public Employees Retirement System of Ohio decreased its holdings in CareDx, Inc (NASDAQ:CDNA - Free Report) by 43.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,385 shares of the compDecember 19, 2024 | marketbeat.comState Street Corp Has $63.58 Million Holdings in CareDx, Inc (NASDAQ:CDNA)State Street Corp decreased its holdings in shares of CareDx, Inc (NASDAQ:CDNA - Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,036,089 shares of the company's stock aftDecember 19, 2024 | marketbeat.comCareDx to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 18, 2024 | uk.finance.yahoo.comLord Abbett & CO. LLC Takes Position in CareDx, Inc (NASDAQ:CDNA)Lord Abbett & CO. LLC purchased a new stake in CareDx, Inc (NASDAQ:CDNA - Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 348,219 shares of the company's stock, valued at approximately $10,873,000. Lord Abbett & CO.December 17, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases New Position in CareDx, Inc (NASDAQ:CDNA)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in CareDx, Inc (NASDAQ:CDNA - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 53,514 shares of the company's stock,December 17, 2024 | marketbeat.comJanus Henderson Group PLC Buys New Stake in CareDx, Inc (NASDAQ:CDNA)Janus Henderson Group PLC purchased a new stake in shares of CareDx, Inc (NASDAQ:CDNA - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 21,900 shares of the company's stock, valued at approDecember 15, 2024 | marketbeat.comVirtue Capital Management LLC Buys New Position in CareDx, Inc (NASDAQ:CDNA)Virtue Capital Management LLC purchased a new position in shares of CareDx, Inc (NASDAQ:CDNA - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 24,169 shares of the company's stock, valued at approximately $755,000. A number ofDecember 12, 2024 | marketbeat.comCareDx, Inc (NASDAQ:CDNA) Given Average Rating of "Hold" by AnalystsCareDx, Inc (NASDAQ:CDNA - Get Free Report) has been assigned a consensus rating of "Hold" from the seven research firms that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy ratingDecember 12, 2024 | marketbeat.comTC Biopharm announces partnership with CareDxDecember 11, 2024 | markets.businessinsider.comCareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell TherapyDecember 11, 2024 | finance.yahoo.com Get CareDx News Delivered to You Automatically Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address CDNA Media Mentions By Week CDNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDNA News Sentiment▼0.060.60▲Average Medical News Sentiment CDNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDNA Articles This Week▼75▲CDNA Articles Average Week Get CareDx News Delivered to You Automatically Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RadNet News BrightSpring Health Services News Sotera Health News Surgery Partners News Veracyte News LifeStance Health Group News Privia Health Group News Concentra Group Holdings Parent News Teladoc Health News Ardent Health Partners News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDNA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareDx, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CareDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
